Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03718416 · ClinicalTrials.gov registry record
Natural History Study of Serious Medical Events in PWS
A clinical trial, sponsored by Foundation for Prader-Willi Research.
- Completed
- Registry status
- 700
- Enrollment target
NCT03718416: Completed study, sponsored by Foundation for Prader-Willi Research.
NCT03718416 is a clinical trial that has completed, run by Foundation for Prader-Willi Research. The registered enrollment target is 700 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03718416 has completed, sponsored by Foundation for Prader-Willi Research.
- COMPLETED
- Registry status
- 700 participants
- Enrollment target
Study Summary
PATH for PWS is a study to help researchers better understand serious medical events in PWS over a 4-year period, as well as evaluate how PWS-related behaviors change over time. The data from this study is intended to inform the development and clinical trial design of potential new treatments.
Primary Outcome
Serious medical events are those that result in death, are life-threatening, require hospitalization or an emergency room visit, or are medically significant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2018-09-28 |
| Est. Completion | 2024-01-31 |
What the finished NCT03718416 record still lists
NCT03718416 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03718416 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03718416 about?
NCT03718416 is a clinical study titled "Natural History Study of Serious Medical Events in PWS". PATH for PWS is a study to help researchers better understand serious medical events in PWS over a 4-year period, as well as evaluate how PWS-related behaviors change over time. The data from this study is intended to inform the development and clinical trial design of potential new treatments.
What is the current status of trial NCT03718416?
This trial is currently completed. The enrollment target is 700 participants. The study started on 2018-09-28. Estimated completion is 2024-01-31.
Who is sponsoring clinical trial NCT03718416?
This trial is sponsored by Foundation for Prader-Willi Research, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI